Navigation Links
Recurrence of SIDS Overestimated: Study

Parents who have lost their first child sudden infant death syndrome (SIDS) shouldnt live in constant fear that the same will happen to their second child, for according to a review study , the recurrence of the syndrome has been overestimated in studies so far.

The authors studied eight population-based studies that have been reported since 1970, and which said the relative risks of cot death recurring ranged from 1.7 to 10.1 times that of the general population.

The review checked to see whether the studies matched three criteria for SIDS:

1.Making sure that all relevant cases of SIDS had been identified reliably
2.Comparing the cases with controls matched for risks of SIDS.
3.Appropriate investigations to ensure that the diagnosis of SIDS was accurate, including an autopsy, tests for familial causes of unexplained death and determining possible homicide.

However, all eight studies failed to meet these three criteria. This failure, the researchers state would have resulted in the risk of SIDS recurrence being overestimated.

All eight studies failed to meet these three criteria, which would have resulted in the risk of recurrence being overestimated, the British Medical Journal quoted the authors, as stating.

We conclude that, although an increase in risk is probable on theoretical grounds, the risk cannot be quantified from the available evidence, they said.

Families whose initial death was fully investigated and who have no major risk factors can be advised that, although the risk of a second death might be slightly increased, it remains very small, they added.

"But my main intention is to get the message across to those parents who have lost their first child that they do not have a significant risk of losing a second," said co-author of the study Dr Christopher Bacon.

The study is published online ahead of print in Archives
'"/>




Page: 1 2

Related medicine news :

1. Lowering Risk of Breast Cancer Recurrence
2. HRT Found To Increase Recurrence of Breast Cancer
3. The Link Between HRT And Recurrence of Breast Cancer
4. Tumour marker for detecting early Recurrence of Thyroid cancer may be soon available
5. Predicting Breast Cancer Recurrence By Understanding Gene Signature
6. Combination Therapy To Avoid Prostate Cancer Recurrence
7. Recurrence of aggressive uterine cancer reduced by new form of therapy
8. Cervical Cancer Recurrence Risk Even After Removal Of Pre-Cancerous Cells
9. Drugs Are Effective In Treating Depression and Preventing Recurrence
10. PET-CT Scores High On Precision for Diagnosing Ovarian Cancer Recurrence
11. Experts Warn of Bird Flu Recurrence in Maharashtra
Post Your Comments:
(Date:12/4/2009)PEMBROKE, Bermuda, Dec. 4 Allied World Assurance,Company Holdings, Ltd (NYSE: AWH ) today announced that Scott Carmilani,President and Chief Executive Officer, and Jack Sennott, Executive Vice,Pres
(Date:12/4/2009)MADISON HEIGHTS, Mich., Dec. 4 The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Allergan, Inc. (NYSE: AGN ) as its February 2010 "Stock to Stud
(Date:12/4/2009)Late recurrence is a risk for some pediatric cancers, particularly Ewing sarcomas and tumors of the central nervous system, according to a new study published online December 4 in the Journal of the
(Date:12/4/2009)More than 15 million Americans are recruited annually to participate in clinical trials according to the Alliance for Human Research Protection (AHRP), and most will be compensated for their participa
(Date:12/4/2009)Increasing exercise, water and fruit consumption leads to success, study finds , , FRIDAY, Dec. 4 (HealthDay News) -- Increased exercise, reduced soda consumption and self-weighing are among
Breaking Medicine News(10 mins):Health News:Allied World to Present at the 2009 Goldman Sachs U.S. Financial Services Conference 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Teens Lose More Weight Using Healthy Strategies 2
...ing based on the ‘survival of the fittest’ theory,...a motive to nurture// the healthy ones, has borne ...ple, the first in UK, after successfully employing...y prone to a condition called cystic fibrosis, a g...
... choice for treatment of influenza is causing pand...sychiatric// side effects, regulators said today. ...fter series of cases of self-injury and mental dis...l approved by U.S FDA cautions medical practitione...
...utt and Yujiang Song from Sandia National Laborat... how a drug attaches //to a cell which involves a ...ctures. Sandia is a National Nuclear Security Admi... currently published the same as an advance public...
...s may do little to improve the use of continuous p...th obstructive sleep apnea (OSA). A new study publ...iewed journal of the American College of Chest Phy...OSA taking a placebo. “CPAP treatment improve...
... and a half years old, is reported to have died fr...spital on Sunday. //The toddler from West Java pro...estic fowl. With this, the death toll, due to this... not related. Most of those affected have caug...
...an opportune time to evaluate the support availabl...orld coping with a galloping disease. Taking// cog...06 - 'Diabetes Care for Everyone, especially the d...w attention towards the communities and groups in ...
Other Medicine News:Health News:Caution:Tamiflu ‘tames’ flu but psychiatric side effects now report 2Health News:Novel methods to view how a drug attaches to a cell 2Health News:Research Questions Use of Sleep Meds for Patients with Apnea 2Health News:The Holy Grail of Diabetes Management 2Health News:The Holy Grail of Diabetes Management 3
(Date:12/4/2009)LAKE FOREST, Ill., Dec. 4 Hospira, Inc. (NYSE: HSP ), a leading global specialty pharmaceutical and medication delivery company, today announced the launch of its next-generation 50 mL and 100 mL V
(Date:12/4/2009)HOUSTON, Dec. 4 OrthoAccel Technologies, Inc., developers of the AcceleDent System , which is an acceleration device to enhance orthodontics, announced the availability of a new Continuing Education
(Date:12/4/2009)WILMINGTON, Del., Dec. 4 AstraZeneca (NYSE: AZN ) today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tab
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 2AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 3AcceleDent Science is Showcased in New Continuing Education Course Published by PennWell 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 14749 1Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 14749 2Oncolytics Biotech 28R 29 Inc Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 14749 3Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 6055 1Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 6055 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 6053 1NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 6053 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 6053 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 6053 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 6053 5
...Department of,Health "unveiled a brand new look fo...a campaign to encourage New Yorker,s to ,get some....uld hand out free condoms at,"busy crossroads," th...and,display ads on subway cars and phone kiosks, a...t year., Robert Peters, President of MIM had the ...
...located in,Houston, Global Healing Center, Inc., a...studies indicating their oxygen colon cleanser is ...tipation and Irritable Bowel,Syndrome. In fact, th...ansing supplement is up to 85% MORE EFFECTIVE AT E... with a zero-percent failure rate., Colon cleansi...
Other Medicine Technology:NYC Department of Health's 'Get Some NYC Condoms' Sends Wrong Message and Misuses Tax Dollars, says MIM President Bob Peters 2Oxygen Relieves IBS and Constipation Symptoms in New Clinical Studies 2
Straight Tissue Forceps
Sanders-Castroviejo Suturing Forceps
Storz Bonn Suturing Forceps
Berens Curved Suturing Forceps
Medicine Products: